CCM
GILD icon

Cutter Capital Management’s Gilead Sciences GILD Stock Holding History

Cutter Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-359,025
Closed -$30.1M – 29
2024
Q3 		$30.1M Buy
359,025
+66,066
+23% +$5.04M 8.88% 1
2024
Q2 		$20.1M Buy
292,959
+27,523
+10% +$1.84M 6.07% 3
2024
Q1 		$19.4M Buy
+265,436
New +$20.4M 7.43% 2

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutter Capital Management's GILD Position: Q4 2024 in Review

Cutter Capital Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 359,025 shares — an estimated $30.1M sold.

Cutter Capital Management first reported a position in GILD in Q1 2024 and held it in 3 quarters. The position peaked at $30.1M in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Cutter Capital Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Cutter Capital Management sold 359,025 Gilead Sciences shares in Q4 2024, an estimated $30.1M.
  • Cutter Capital Management first reported a position in Gilead Sciences in Q1 2024 and held it in 3 quarters.
  • Cutter Capital Management's Gilead Sciences position peaked at $30.1M in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Cutter Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.